세계의 피나스테라이드 시장 규모 조사 및 예측 : 유형별, 유통 채널별, 용도별, 지역별 분석(2023-2030년)

Global Finasteride Market is valued at approximately USD 377.31 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2023-2030. Finasteride is a medication that is primarily used to treat benign prostatic hyperplasia (BPH), a disorder that causes men to have an enlarged prostate gland. It is also prescribed for the treatment of male pattern hair loss, a common condition in which men experience hair thinning or hair loss on the scalp. The medication is a sort of 5-alpha-reductase inhibitor, which means that it prevents testosterone from being converted to dihydrotestosterone (DHT), a hormone that causes hair loss and enlargement of the prostate. The rise in prevalence of male pattern baldness, growing awareness about benign prostatic hyperplasia and hair loss, and introduction of novel formulations, coupled with the growing consumer spending on hair care products are the major factors that are fueling the market demand around the world.

In addition, the increasing incidences of Benign Prostatic Hyperplasia (BPH) drive the demand for various medications such as finasteride that are specifically indicated for its treatment. According to Johns Hopkins Medicine, it is estimated that approximately 20% to 30% of men experience BPH symptoms severe enough to require treatment by age 80. Thus, these aforementioned factors are propelling the growth of the Finasteride Market during the estimated period. Moreover, the rising research and development activities, as well as advancements in healthcare infrastructure present various lucrative opportunities over the forecast years. However, the side effects associated with finasteride and availability of alternate medicine are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Finasteride Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing healthcare spending, and surge in investments for the development of finasteride. coupled with the growing awareness about finasteride. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecastyears. The surge in the prevalence of male pattern baldness cases, rise in the number of key players, and increasing aging population are significantly propelling the market demand across the region.

Major market players included in this report are:

• Aurobindo Pharma Limited
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Organon & Co.
• Cipla Ltd
• Intas Pharmaceuticals Ltd.
• HETERO LABS LIMITED
• Alkem Laboratories Ltd
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.

Recent Developments in the Market:

• In January 2023, Happy Head announced the introduction of the company's new SuperCapsulesTM for hair growth, which is developed by top-notch dermatologists and hair restoration specialists. These SuperCapsulesTM are the first of their type as they combine three FDA-approved medications-Finasteride, Minoxidil, and Vitamin D-into a single daily pill.

Global Finasteride Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, Distribution Channel, Application, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Branded
• Generic

By Distribution Channel:

• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies

By Application:

• Benign Prostatic Hyperplasia (BPH)
• Male pattern baldness

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Finasteride Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Finasteride Market, by Type, 2020-2030 (USD Million)
  • 1.2.3. Finasteride Market, by Distribution Channel, 2020-2030 (USD Million)
  • 1.2.4. Finasteride Market, by Application, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Finasteride Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Finasteride Market Dynamics

• 3.1. Finasteride Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of Benign Prostatic Hyperplasia
    • 3.1.1.2. Growing consumer spending on hair care products
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects associated with finasteride
    • 3.1.2.2. Availability of alternate
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising research and development activities
    • 3.1.3.2. Advancements in healthcare infrastructure

Chapter 4. Global Finasteride Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Finasteride Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Finasteride Market by Type, Performance - Potential Analysis
• 5.3. Global Finasteride Market Estimates & Forecasts by Type 2020-2030 (USD Million)
• 5.4. Finasteride Market, Sub Segment Analysis
  • 5.4.1. Branded
  • 5.4.2. Generic

Chapter 6. Global Finasteride Market, by Distribution Channel

• 6.1. Market Snapshot
• 6.2. Global Finasteride Market by Distribution Channel, Performance - Potential Analysis
• 6.3. Global Finasteride Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
• 6.4. Finasteride Market, Sub Segment Analysis
  • 6.4.1. Hospital Pharmacies
  • 6.4.2. Online Providers
  • 6.4.3. Drug Stores and Retail Pharmacies

Chapter 7. Global Finasteride Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Finasteride Market by Application, Performance - Potential Analysis
• 7.3. Global Finasteride Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 7.4. Finasteride Market, Sub Segment Analysis
  • 7.4.1. Benign Prostatic Hyperplasia (BPH)
  • 7.4.2. Male pattern baldness

Chapter 8. Global Finasteride Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Finasteride Market, Regional Market Snapshot
• 8.4. North America Finasteride Market
  • 8.4.1. U.S. Finasteride Market
    • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Finasteride Market
• 8.5. Europe Finasteride Market Snapshot
  • 8.5.1. U.K. Finasteride Market
  • 8.5.2. Germany Finasteride Market
  • 8.5.3. France Finasteride Market
  • 8.5.4. Spain Finasteride Market
  • 8.5.5. Italy Finasteride Market
  • 8.5.6. Rest of Europe Finasteride Market
• 8.6. Asia-Pacific Finasteride Market Snapshot
  • 8.6.1. China Finasteride Market
  • 8.6.2. India Finasteride Market
  • 8.6.3. Japan Finasteride Market
  • 8.6.4. Australia Finasteride Market
  • 8.6.5. South Korea Finasteride Market
  • 8.6.6. Rest of Asia Pacific Finasteride Market
• 8.7. Latin America Finasteride Market Snapshot
  • 8.7.1. Brazil Finasteride Market
  • 8.7.2. Mexico Finasteride Market
• 8.8. Middle East & Africa Finasteride Market
  • 8.8.1. Saudi Arabia Finasteride Market
  • 8.8.2. South Africa Finasteride Market
  • 8.8.3. Rest of Middle East & Africa Finasteride Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Aurobindo Pharma Limited
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Sun Pharmaceutical Industries Ltd.
  • 9.3.3. Dr. Reddy's Laboratories Ltd.
  • 9.3.4. Organon & Co.
  • 9.3.5. Cipla Ltd
  • 9.3.6. Intas Pharmaceuticals Ltd.
  • 9.3.7. HETERO LABS LIMITED
  • 9.3.8. Alkem Laboratories Ltd
  • 9.3.9. Teva Pharmaceutical Industries Ltd.
  • 9.3.10. Merck & Co., Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption